NR3C2 and heart failure: Studies examining drugs for heart failure, such as inhibitors of angiotensin-converting enzyme, mineralocorticoid receptors, diuretics, and beta blockers, randomized selected patients to drugs with the tested active substance and to placebo [73,74,75,76].